Enhanced membrane pore formation through high-affinity targeted antimicrobial peptides

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Arnusch, Christopher J ^a   Pieters, Roland J ^a   Breukink, Eefjan ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DALBAVANCIN; MAGAININ 2; ORITAVANCIN; POLYPEPTIDE ANTIBIOTIC AGENT; TELAVANCIN; VANCOMYCIN;

ARTICLE; CELL MEMBRANE; CELL PERMEABILIZATION; CLICK CHEMISTRY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; ERYTHROCYTE; EUKARYOTIC CELL; HUMAN; HUMAN CELL; VANCOMYCIN RESISTANT ENTEROCOCCUS; WHOLE CELL;

AMINO ACID SEQUENCE; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIA; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CLICK CHEMISTRY; ERYTHROCYTES; HEMOLYSIS; HUMANS; MAGAININS; MEMBRANE LIPIDS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; UNILAMELLAR LIPOSOMES; VANCOMYCIN;

EUKARYOTA; PROKARYOTA;

EID: 84863097110     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039768     Document Type: Article

References (28)

1. Zasloff M, (2002) Antimicrobial peptides of multicellular organisms. Nature 415: 389-395.
2. Matsuzaki K, (1999) Why and how are peptide-lipid unteractions utilized for self defense? Magainins and tachyplesins as archyetypes. Biochim Biophys Acta 1462: 1-10.
3. Riedl S, Zweytick D, Lohner K, (2011) Membrane-active host defense peptides-challenges and perspectives for the development of novel anticancer drugs. Chem Phys Lipids 164: 766-781.
4. Schweizer F, (2009) Cationic amphiphilic peptides with cancer-selective toxicity. Eur J Pharmacol 625: 190-194.
5. Hoskin DW, Ramamoorthy A, (2008) Studies on anticancer activities of antimicrobial peptides. Biochim Biophys Acta 1778: 357-375.
6. Zasloff M, (1987) Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc Natl Acad Sci U S A 84: 5449-5453.
7. Oren Z, Shai Y, (1998) Mode of action of linear amphipathic alpha-helical antimicrobial peptides. Biopolymers 47: 451-463.
8. Darveau RP, Cunningham MD, Seachord CL, Cassiano-Clough L, Cosand WL, et al. (1991) Beta-lactam antibiotics potentiate magainin 2 antimicrobial activity in vitro and in vivo. Antimicrob Agents Chemother 35: 1153-1159.
9. Nguyen LT, Haney EF, Vogel HJ, (2011) The expanding scope of antimicrobial peptide structures and their modes of action. Trends Biotechnol 29: 464-472.
10. Jenssen H, Hamill P, Hancock RE, (2006) Peptide antimicrobial agents. Clin Microbiol Rev 19: 491-511.
11. Shai Y, (2002) Mode of action of membrane active antimicrobial peptides. Biopolymers 66: 236-248.
12. Utsugi T, Schroit AJ, Connor J, Bucana CD, Fidler IJ, (1991) Elevated expression of phosphatidylserine in the outer membrane leaflet of human tumor cells and recognition by activated human blood monocytes. Cancer Res 51: 3062-3066.
13. Ho SB, Niehans GA, Lyftogt C, Yan PS, Cherwitz DL, et al. (1993) Heterogeneity of mucin gene expression in normal and neoplastic tissues. Cancer Res 53: 641-651.
14. Cruciani RA, Barker JL, Zasloff M, Chen HC, Colamonici O, (1991) Antibiotic magainins exert cytolytic activity against transformed cell lines through channel formation. Proc Natl Acad Sci USA 88: 3792-3796.
15. Breukink E, de Kruijff B, (2006) Lipid II as a target for antibiotics. Nat Rev Drug Discov 5: 321-332.
16. Breukink E, de Kruijff B, (1999) The lantibiotic nisin, a special case or not? Biochim Biophys Acta 1462: 223-234.
17. Hsu ST, Breukink E, Tischenko E, Lutters MA, de Kruijff B, et al. (2004) The nisin-lipid II complex reveals a pyrophosphate cage that provides a blueprint for novel antibiotics. Nat Struct Mol Biol 11: 963-967.
18. Wiedemann I, Benz R, Sahl HG, (2004) Lipid II-mediated pore formation by the peptide antibiotic nisin: a black lipid membrane study. J Bacteriol 186: 3259-3261.
19. Breukink E, Wiedemann I, van Kraaij C, Kuipers OP, Sahl H, et al. (1999) Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic. Science 286: 2361-2364.
20. Hasper HE, de Kruijff B, Breukink E, (2004) Assembly and stability of nisin-lipid II pores. Biochemistry 43: 11567-11575.
21. Richard A Houghten, JHC (1994) Substitution analogues of magainin peptides, Scripps Clinic and Research Foundation, US Patent 5912231.
22. Meldal M, Tornoe CW, (2008) Cu-catalyzed azide-alkyne cycloaddition. Chem Rev 108: 2952-3015.
23. Arnusch CJ, Branderhorst H, de Kruijff B, Liskamp RM, Breukink E, et al. (2007) Enhanced membrane pore formation by multimeric/oligomeric antimicrobial peptides. Biochemistry 46: 13437-13442.
24. Arnusch CJ, Bonvin AM, Verel AM, Jansen WT, Liskamp RM, et al. (2008) The vancomycin-nisin(1-12) hybrid restores activity against vancomycin resistant Enterococci. Biochemistry 47: 12661-12663.
25. Fernandez DI, Gehman JD, Separovic F, (2009) Membrane interactions of antimicrobial peptides from Australian frogs. Biochim Biophys Acta 1788: 1630-1638.
26. Shai Y, (1999) Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim Biophys Acta. 1462: 55-70.
27. Chamorro C, Boerman MA, Arnusch CJ, Breukink E, Pieters RJ, (2012) Enhancing membrane disruption by targeting and multivalent presentation of antimicrobial peptides. Biochimica et Biophysica Acta, In press DOI 10.1016/j.bbamem.2012.04.004.
28. Breukink E, van Kraaij C, Demel RA, Siezen RJ, Kuipers OP, de Kruijff B, (1997) The C-terminal region of nisin is responsible for the initial interaction of nisin with the target membrane. Biochemistry 36: 6968-6976.